Nuvation Bio (NUVB) Gross Margin (2024 - 2026)

Nuvation Bio (NUVB) posted quarterly Gross Margin of 99.55% for Q1 2026, up 6745.0% year-over-year from 1.45% in Q1 2025, and down 14.99% quarter-over-quarter from 117.11% in Q4 2025.

Nuvation Bio (NUVB) Gross Margin (2024 - 2026) Analysis & Trends

Nuvation Bio (NUVB) has reported Gross Margin for 3 consecutive years, with 99.55% the latest figure, recorded in Q1 2026.

  • In Q1 2026, Gross Margin rose 6745.0% year-over-year to 99.55%; the TTM figure through Mar 2026 stood at 100.6% (up 8431.0% YoY), while the FY2025 annual figure was 98.64%, up 8854.0% from the prior year.
  • Gross Margin retreated to 99.55% in Q1 2026 per NUVB's latest filing, from 117.11% in the prior quarter.
  • Across five years, Gross Margin topped out at 117.11% in Q4 2025 and bottomed at 108.39% in Q3 2024.
  • Historically, Gross Margin has averaged 36.73% across 3 years, with a median of 39.4% in 2025.
  • On a YoY basis, Gross Margin climbed as much as 18286 bps in 2025 and fell as far as 4057 bps in 2025.
  • Nuvation Bio's Gross Margin stood at 26.18% in 2024, then surged by 347 bps to 117.11% in 2025, then slipped by 15 bps to 99.55% in 2026.
  • Business Quant data shows NUVB's Gross Margin at 99.55% in Q1 2026, 117.11% in Q4 2025, and 74.47% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 85.33%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 91.59%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 90.68%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 89.76%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 60,631,834.75%
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 76.90%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 84.20%
10 Nuvation Bio 2.16 Bn 2.16 Bn 30.78 Mn 97.13%

Historic Data

Download Data
DateValue
Jun 30, 2026 97.13%
Mar 31, 2026 99.55%
Dec 31, 2025 117.11%
Sep 30, 2025 74.47%
Jun 30, 2025 46.70%
Mar 31, 2025 32.10%
Dec 31, 2024 26.18%
Sep 30, 2024 -108.39%
Jun 30, 2024 6.13%